40 results on '"Hirakawa, Miharu"'
Search Results
2. Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinoma
3. Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load
4. Amino Acid Substitutions in Hepatitis C Virus Core Region Predict Hepatocarcinogenesis Following Eradication of HCV RNA by Antiviral Therapy
5. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model
6. Influence of Itpa Polymorphisms on Decreases of Hemoglobin During Treatment With Pegylated Interferon, Ribavirin, And Telaprevir
7. Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
8. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
9. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
10. Treatment of patients with resistant mutants against nucleos(t)ide analogs: Plenary Session 5: Treatment (Resistant Mutants against NA)
11. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients
12. Virus Clearance Reduces Bone Fracture in Postmenopausal Women With Osteoporosis and Chronic Liver Disease Caused by Hepatitis C Virus
13. Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
14. Losartan Reduces the Onset of Type 2 Diabetes in Hypertensive Japanese Patients With Chronic Hepatitis C
15. Amino Acid Substitutions in the Hepatitis C Virus Core Region of Genotype 1b Are the Important Predictor of Severe Insulin Resistance in Patients Without Cirrhosis and Diabetes Mellitus
16. Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma
17. Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
18. A Matched Case-Controlled Study of 48 and 72 Weeks of Peginterferon Plus Ribavirin Combination Therapy in Patients Infected With HCV Genotype 1b in Japan: Amino Acid Substitutions in HCV Core Region as Predictor of Sustained Virological Response
19. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle
20. Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C Patients
21. Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment.
22. Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy.
23. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.
24. Clinical and virological effects of long-term (over 5 years) lamivudine therapy.
25. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
26. Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases.
27. Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 2a High Viral Load and Virological Response to Interferon-Ribavirin Combination Therapy.
28. Virological and Biochemical Features in Elderly HCV Patients with Hepatocellular Carcinoma: Amino Acid Substitutions in HCV Core Region as Predictor of Mortality after First Treatment.
29. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
30. Lipiodol and Dye at the Site of Ablation Decreases during RFA.
31. The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load.
32. Efficacy in Patients with Dose Reduction in Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C.
33. Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir
34. Relationship between Alcohol Intake and Risk Factors for Metabolic Syndrome in Men.
35. Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load.
36. Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load.
37. The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.
38. Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus load.
39. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.
40. Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.